(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIDORES DE FERROPORTINA PARA O USO NO TRATAMENTO DE BETA-TALASSEMIA DEPENDENTE DE TRANSFUSÃO (TDT)

Em ExigênciaInvention PatentPCT · EP2020070391

Application data

Number

112022001062

Type

Invention Patent

Filing

07/17/2020

Publication

03/15/2022

PCT

EP2020070391

Progress at the INPI

Technical opinion to answer
  1. Filing07/17/20
  2. Publication03/15/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 06/23/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

VIFOR (INTERNATIONAL) AG

CH

See this company's full portfolio

Inventors

F. D. (pessoa física)

CH

N. N. (pessoa física)

CH

P. A. (pessoa física)

CH

V. M. (pessoa física)

CH

Technical data

Priority claims

EP

19187248.0 · 07/19/2019

EP

20174230.1 · 05/12/2020

Abstract

INIBIDORES DE FERROPORTINA PARA O USO NO TRATAMENTO DE BETA-TALASSEMIA DEPENDENTE DE TRANSFUSÃO (TDT). A invenção se refere ao uso de compostos inibidores de ferroportina da fórmula geral (I) para tratar ß-talassemia dependente de transfusão.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

06/23/2026

RPI 2894

Notificação de entrada na fase nacional - PCT

#1.3

03/15/2022

RPI 2671

Alteração de dados cadastrais

#1.1

02/01/2022

RPI 2665

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.